A Closer Look at 28 Analyst Recommendations For Sarepta Therapeutics
A Closer Look at 28 Analyst Recommendations For Sarepta Therapeutics
对Sarepta Therapeutics的28个分析师建议进行更详细的分析
Sarepta Therapeutics (NASDAQ:SRPT) has been analyzed by 28 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去三个月中，28位分析师对Sarepta Therapeutics（纳斯达克股票代码：SRPT）进行了分析，揭示了从看涨到看跌的不同视角。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $185.0, a high estimate of $235.00, and a low estimate of $128.00. This current average has increased by 6.54% from the previous average price target of $173.65.
分析师分析的12个月目标股价提供了见解，平均目标股价为185.0美元，最高估计为235.00美元，低估值为128.00美元。目前的平均价格较之前的平均目标价173.65美元上涨了6.54％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
A comprehensive examination of how...
对金融专家...
登录免费看全文
登录/注册